K4L SURFACTANT AEROSOL TO REDUCE INFLUENZA LUNG INJURY
$225,000N43FY2015AINIH
Discovery Laboratories, Inc., Warrington PA
Investigators
Abstract
To support the development of a broadly applicable therapy directed at modulating host factors and immune-mediated processes to reduce lung injury and immunopathology in serious influenza.
View original record on NIH RePORTER →